Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01650675 · ClinicalTrials.gov registry record · Phase 2
Indirect Assessment and Intervention for Perinatal Drug Use
A Phase 2 study of Drug Abuse, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT01650675: Completed Phase 2 study of Drug Abuse, sponsored by Wayne State University.
NCT01650675 is a Phase 2 study of Drug Abuse that has completed, run by Wayne State University. The registered enrollment target is 500 participants, above the 302-participant average among 21 other Drug Abuse trials with a reported enrollment target (66% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01650675, a Phase 2 study of Drug Abuse, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the validity of an indirect computer-delivered screener for drug use and assess the efficacy of a computer-delivered brief intervention with urban post-partum women at-risk for substance abuse and HIV during the post-partum period.
Primary Outcome
Drug use over past 90 days will be measured at a 3 and 6-month follow-up by self-report, hair, and urine analysis.
Conditions Studied
Interventions
- BEHAVIORAL WIDUS computer-delivered, indirect brief intervention
- BEHAVIORAL Nutrition time control/placebo intervention
Study Locations (1)
Michigan
- Wayne State University - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-05 |
| Phase | Phase 2 |
What the finished NCT01650675 record still lists
NCT01650675 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 302-participant average among 21 other Drug Abuse trials with a reported enrollment target (66% higher).
The record links to 1 condition, with Drug Abuse appearing as the primary indexed condition, and to 2 interventions - of which WIDUS computer-delivered, indirect brief intervention is the first listed.
NCT01650675 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01650675 about?
NCT01650675 is a clinical study titled "Indirect Assessment and Intervention for Perinatal Drug Use". The purpose of this study is to assess the validity of an indirect computer-delivered screener for drug use and assess the efficacy of a computer-delivered brief intervention with urban post-partum women at-risk for substance abuse and HIV during the post-partum period.
What is the current status of trial NCT01650675?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 500 participants. The study started on 2012-06. Estimated completion is 2015-05.
What conditions does trial NCT01650675 study?
This clinical trial studies the following conditions: Drug Abuse.
What interventions are being tested in trial NCT01650675?
The interventions under investigation include: WIDUS computer-delivered, indirect brief intervention (BEHAVIORAL), Nutrition time control/placebo intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01650675?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01650675 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01650675's enrollment target sits among peer trials
500 5th of 21 higher than 17 of 21 other Drug Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Drug Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Youth Drug Abuse Family and Cognitive-Behavioral Therapy
COMPLETED · Phase 2
-
Wakaya: Rising Up for Choctaw Youth Health
RECRUITING · NA
-
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
RECRUITING · NA
-
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
RECRUITING · NA
-
OUD Smartphone Services
ACTIVE NOT RECRUITING · NA
-
Adolescent Family-Based Alcohol Prevention
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia